Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from TYK Medicines, Inc. Class H ( (HK:2410) ) is now available.
TYK Medicines, Inc, a joint stock company incorporated in the People’s Republic of China, has announced that its Board of Directors will convene on August 31, 2025. The meeting will focus on approving the interim results for the first half of 2025 and discussing the potential payment of an interim dividend. This announcement signals the company’s commitment to transparency and shareholder engagement, potentially impacting its market position and investor relations.
The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.
More about TYK Medicines, Inc. Class H
Average Trading Volume: 4,096,991
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$7.21B
See more data about 2410 stock on TipRanks’ Stock Analysis page.